LON:SER 5533861 (SER.L) (SER) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About 5533861 (SER.L) Stock (LON:SER) 30 days 90 days 365 days Advanced Chart Get 5533861 (SER.L) alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume60.79 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSefton Resources, Inc. is a United States-based company, which is engaged in the exploration, development and production of oil and natural gas. The Company is also engaged in gathering and transporting natural gas in the Continental United States. The Company's properties are located in California and Kansas, the United States. It has approximately 40,000 acres in the Forest City Basin of Eastern Kansas to develop Coal Bed Methane gas, as well as conventional oil and gas projects. The Company also owns a transmission pipeline in Kansas. The Company's subsidiaries include TEG MidContinent and TEG Transmission.Read More… Receive SER Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 5533861 (SER.L) and its competitors with MarketBeat's FREE daily newsletter. Email Address SER Stock News HeadlinesRegistration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"June 9 at 4:05 PM | globenewswire.comSerina Therapeutics Appoints Stephen Brannan, M.D. to Board of DirectorsMay 22, 2025 | globenewswire.comTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.June 12, 2025 | Porter & Company (Ad)Serina Therapeutics Makes Grants to New Employees Under Inducement PlanMay 14, 2025 | globenewswire.comSerina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business HighlightsMay 8, 2025 | globenewswire.comSerina Therapeutics to Present at JonesResearch Virtual CNS DayApril 29, 2025 | globenewswire.comSerina Therapeutics to Present at the 4th LNP Formulation & Process Development SummitApril 15, 2025 | globenewswire.comSerina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's DiseaseApril 8, 2025 | globenewswire.comSee More Headlines SER Stock Analysis - Frequently Asked Questions How do I buy shares of 5533861 (SER.L)? Shares of SER stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of 5533861 (SER.L) own? Based on aggregate information from My MarketBeat watchlists, some other companies that 5533861 (SER.L) investors own include Serco Group (SRP), Sosandar (SOS), Cadence Minerals (KDNC), Gulf Keystone Petroleum (GKP) and Echo Energy (ECHO). Industry, Sector and Symbol Stock ExchangeLON SectorManufacturing Industry Pharmaceutical Preparations Sub-IndustryPharmaceutical Products Current SymbolLON:SER CIKN/A Webwww.seftonresources.com Phone+44-20-78725570FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (LON:SER) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s final win for Social Security?Elon's Successor? Elon Musk and President Trump's new feud is all over the news... but before he left Washi...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 5533861 (SER.L) Please log in to your account or sign up in order to add this asset to your watchlist. Share 5533861 (SER.L) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.